ATE255562T1 - Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäur guaiacyl ester (med 15) - Google Patents

Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäur guaiacyl ester (med 15)

Info

Publication number
ATE255562T1
ATE255562T1 AT98962664T AT98962664T ATE255562T1 AT E255562 T1 ATE255562 T1 AT E255562T1 AT 98962664 T AT98962664 T AT 98962664T AT 98962664 T AT98962664 T AT 98962664T AT E255562 T1 ATE255562 T1 AT E255562T1
Authority
AT
Austria
Prior art keywords
toluoylpyrrole
methyl
med
new crystalline
acetamidoacetic acid
Prior art date
Application number
AT98962664T
Other languages
English (en)
Inventor
Sergio Anzalone
Original Assignee
Sigma Tau Ind Farmaceuti
Medosan Ind Biochimi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Medosan Ind Biochimi filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE255562T1 publication Critical patent/ATE255562T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
AT98962664T 1997-12-24 1998-12-16 Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäur guaiacyl ester (med 15) ATE255562T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000811A IT1297140B1 (it) 1997-12-24 1997-12-24 Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e
PCT/IT1998/000363 WO1999033797A1 (en) 1997-12-24 1998-12-16 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)

Publications (1)

Publication Number Publication Date
ATE255562T1 true ATE255562T1 (de) 2003-12-15

Family

ID=11405418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962664T ATE255562T1 (de) 1997-12-24 1998-12-16 Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäur guaiacyl ester (med 15)

Country Status (22)

Country Link
US (1) US6288241B1 (de)
EP (1) EP1082304B1 (de)
JP (1) JP4693236B2 (de)
KR (1) KR100554704B1 (de)
CN (1) CN1200930C (de)
AT (1) ATE255562T1 (de)
AU (1) AU781283B2 (de)
BR (1) BR9814476A (de)
CA (1) CA2315835C (de)
CZ (1) CZ297132B6 (de)
DE (1) DE69820301T2 (de)
DK (1) DK1082304T3 (de)
ES (1) ES2210853T3 (de)
HK (1) HK1035717A1 (de)
HU (1) HU228112B1 (de)
IL (1) IL136828A (de)
IT (1) IT1297140B1 (de)
PL (1) PL197768B1 (de)
PT (1) PT1082304E (de)
SK (1) SK284777B6 (de)
TR (1) TR200001867T2 (de)
WO (1) WO1999033797A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020175023A1 (ja) * 2019-02-28 2020-09-03 国立大学法人東京工業大学 アミドの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1210673B (it) * 1982-02-26 1989-09-20 Medosan Ind Biochimi Antinfiammatoria amidi pirrolacetiche ad attivita'
IT1148117B (it) * 1982-03-05 1986-11-26 Medosan Ind Biochimi Attivita'antiflogistica,analgesica,antipiretica,mucolitica e seda tiva della tosse dell'1 metil-5-p-tolilpirrol-2-acetato di 2'metossi-fenile
IT1197688B (it) * 1983-07-29 1988-12-06 Medosan Ind Biochimi Attivita' antiflogistica,analgesica,antipiretica ed antiaggregante piastrinica di 1-metil-5-metilbenzoilpirrol-2-acetamido acetanilidi
IT1278144B1 (it) * 1995-07-14 1997-11-17 Medosan Ricerca Srl Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.
WO1999007363A1 (en) * 1997-08-08 1999-02-18 Medosan, Ricerca S.R.L. Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment

Also Published As

Publication number Publication date
SK284777B6 (sk) 2005-11-03
HUP0101025A1 (hu) 2001-08-28
WO1999033797A1 (en) 1999-07-08
BR9814476A (pt) 2000-10-10
HUP0101025A3 (en) 2001-09-28
JP4693236B2 (ja) 2011-06-01
ES2210853T3 (es) 2004-07-01
EP1082304A1 (de) 2001-03-14
IL136828A0 (en) 2001-06-14
US6288241B1 (en) 2001-09-11
DE69820301D1 (de) 2004-01-15
AU781283B2 (en) 2005-05-12
KR20010033497A (ko) 2001-04-25
CA2315835C (en) 2008-03-25
SK8952000A3 (en) 2000-12-11
HK1035717A1 (en) 2001-12-07
DE69820301T2 (de) 2004-10-14
CZ20002336A3 (cs) 2000-12-13
EP1082304B1 (de) 2003-12-03
TR200001867T2 (tr) 2000-12-21
PL197768B1 (pl) 2008-04-30
CA2315835A1 (en) 1999-07-08
AU1782899A (en) 1999-07-19
CN1200930C (zh) 2005-05-11
IT1297140B1 (it) 1999-08-03
CN1283185A (zh) 2001-02-07
KR100554704B1 (ko) 2006-02-24
ITRM970811A1 (it) 1999-06-24
CZ297132B6 (cs) 2006-09-13
HU228112B1 (en) 2012-11-28
DK1082304T3 (da) 2004-04-05
JP2001527064A (ja) 2001-12-25
PT1082304E (pt) 2004-04-30
IL136828A (en) 2005-08-31
PL341424A1 (en) 2001-04-09

Similar Documents

Publication Publication Date Title
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
YU17796A (sh) Kristalni oblik 2-metil-tieno-benzodiazepina, njegove farmaceutske formulacije i postupak za njegovo dobijanje
PT1090029E (pt) 14,15-ciclopropanoesteroides da serie dos 19-norandrostanos, processo para a sua producao e preparacoes farmaceuticas contendo estes compostos
ATE250034T1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
ATE260252T1 (de) Thiocolchicin-derivate mit entzündungshemmender und muskelrelaxierender wirkung
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
ATE229518T1 (de) Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
NO982229L (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som anti-inflammatoriske midler
ATE255562T1 (de) Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäur guaiacyl ester (med 15)
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
IE781291L (en) Psychopharmacological peptides
PT83472B (pt) Processo para a preparacao de composicoes anti-inflamatorias aperfeicoadas contendo piroxicamo
ATE239739T1 (de) Phospholipid-derivate von nichtsteroiden entzündungshemmenden medikamenten
DK0937057T3 (da) Hidtil ukendte (-)-enantiomerer af cis-3,4-chromanderivater anvendelige i forebyggelse eller behandling af østrogenrelaterede sygdomme eller syndromer
DE69717844T2 (de) Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromen
AU605164B2 (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs
BR9813102A (pt) Derivados de ácido metilenobisfosfÈnico novos
IT8421609A0 (it) Estere dell'acido (+)6-metossi-alfa-metil-2-naftalenacetico avente attivita'mucosecretolitica, antinfiammatoria, analgesica, antipiretica, procedimento per lasua preparazione e sue composizioni farmaceutiche.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
IT8522978A0 (it) Estere dell'acido alfa-metil-4-(2-tienilcarbonil)benzenacetico avente attivita'mucosecretolitica, antiinfiammatoria, analgesica, antipiretica, procedimento per lasua preparazione e sue composizioni farmaceutiche.
PT81758A (de) Neue n-(2-hydroxyalkyl)-aminosaueren und ihre derivate verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DK32789A (da) Derivat af antibiotikum a 42867

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1082304

Country of ref document: EP